3-HYDROXY-2,3-DIHYDROBENZOFURAN (OR BENZOTHIOPHENE) DERIVATIVE AND LIVER DISEASE TREATING AGENT
展开▼
机译:3-羟基-2,3-二氢苯并呋喃(或苯并噻吩)衍生物和肝脏疾病治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
PROBLEM TO BE SOLVED: To obtain a new compound having high safety, active even by oral use and useful as an excellent liver disease treating agent. ;SOLUTION: A compound of formula I (R1 and R2 are each H, a lower alkyl or the like; R3 and R4 are each H, a lower alkyl or the like; R5a and R5b are each H, a lower alkyl or the like; R6 is H or the like; X is oxygen or the like; here, all of R1, R2 and R3 can not be acyl groups at the same time), preferably, 3, 4-dihydroxy-6-methoxy-2, 2-dimethyl-2,3-dihydrobenzofuran or the like. The compound of formula I is obtained, for example, by reducing a compound of formula II (e.g. 4-hydroxy-6-methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-3-one) in an inactive solvent such as tetrahydrofuran with a reducing agent such as lithium aluminum hydride. This new compound is useful for treating and preventing acute hepatitis, chronic hepatitis, drug induced toxic hepatopathy or the like.;COPYRIGHT: (C)1999,JPO
展开▼
机译:要解决的问题:获得一种新的化合物,该化合物具有高安全性,甚至通过口服使用也具有活性,并且可用作优良的肝脏疾病治疗剂。 ;解决方案:式I的化合物(R 1 Sup>和R 2 Sup>分别是H,低级烷基等; R 3 Sup>和R 4 Sup>分别为H,低级烷基等; R 5a Sup>和R 5b Sup>分别为H,低级烷基等; R 6 Sup>是H等; X是氧等;这里,R 1 Sup>,R 2 Sup>和R 3全部 Sup>不能同时为酰基),最好是3,4-二羟基-6-甲氧基-2、2-二甲基-2,3-二氢苯并呋喃等。式I的化合物例如是通过在惰性溶剂(例如)中还原式II的化合物(例如4-羟基-6-甲氧基-2,2-二甲基-2,3-二氢苯并呋喃-3-酮)而获得的。四氢呋喃与还原剂,例如氢化铝锂。该新化合物可用于治疗和预防急性肝炎,慢性肝炎,药物引起的中毒性肝病等。版权所有:(C)1999,JPO
展开▼